Switch theme
Sign up to access all valuation multiples
Coltene Holding AG is a Switzerland based company engaged in developing, manufacturing, and selling a range of disposables and tools for dentists and dental laboratories. The company divides its comprehensive product range into categories such as Infection Control, Dental Preservation, and Efficient Treatment categories. It offers products like aspirator tips, high-performance rotary instruments, dental dams and root canal instruments among others. The firm has its geographic presence in EMEA, North America, Latin America, and Asia/Oceania regions.
2005
1.2K+
LTM Revenue $286M
LTM EBITDA $39.8M
$416M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Coltene has a last 12-month revenue of $286M and a last 12-month EBITDA of $39.8M.
In the most recent fiscal year, Coltene achieved revenue of $283M and an EBITDA of $38.7M.
Coltene expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Coltene valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $274M | $283M | XXX | XXX | XXX |
| Gross Profit | $190M | $166M | XXX | XXX | XXX |
| Gross Margin | 69% | 59% | XXX | XXX | XXX |
| EBITDA | $26.9M | $38.7M | XXX | XXX | XXX |
| EBITDA Margin | 10% | 14% | XXX | XXX | XXX |
| Net Profit | $29.4M | $13.5M | XXX | XXX | XXX |
| Net Margin | 11% | 5% | XXX | XXX | XXX |
| Net Debt | $25.8M | $30.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Coltene's stock price is CHF 59 (or $66).
Coltene has current market cap of CHF 350M (or $395M), and EV of CHF 368M (or $416M).
See Coltene trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $416M | $395M | XXX | XXX | XXX | XXX | $4.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Coltene has market cap of $395M and EV of $416M.
Coltene's trades at 1.5x LTM EV/Revenue multiple, and 10.4x LTM EBITDA.
Analysts estimate Coltene's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Coltene and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $416M | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 10.7x | XXX | XXX | XXX |
| P/E | 17.1x | XXX | XXX | XXX |
| P/E/Growth | 1.6x | XXX | XXX | XXX |
| EV/FCF | 16.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpColtene's NTM/LTM revenue growth is 4%
Coltene's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Coltene's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Coltene's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Coltene and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 44% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 17% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 52% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Coltene acquired XXX companies to date.
Last acquisition by Coltene was XXXXXXXX, XXXXX XXXXX XXXXXX . Coltene acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Coltene founded? | Coltene was founded in 2005. |
| Where is Coltene headquartered? | Coltene is headquartered in Switzerland. |
| How many employees does Coltene have? | As of today, Coltene has 1.2K+ employees. |
| Is Coltene publicy listed? | Yes, Coltene is a public company listed on SWX. |
| What is the stock symbol of Coltene? | Coltene trades under CLTN ticker. |
| When did Coltene go public? | Coltene went public in 2006. |
| Who are competitors of Coltene? | Similar companies to Coltene include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Coltene? | Coltene's current market cap is $395M |
| What is the current revenue of Coltene? | Coltene's last 12-month revenue is $286M. |
| What is the current EBITDA of Coltene? | Coltene's last 12-month EBITDA is $39.8M. |
| What is the current EV/Revenue multiple of Coltene? | Current revenue multiple of Coltene is 1.5x. |
| What is the current EV/EBITDA multiple of Coltene? | Current EBITDA multiple of Coltene is 10.4x. |
| What is the current revenue growth of Coltene? | Coltene revenue growth between 2023 and 2024 was 3%. |
| Is Coltene profitable? | Yes, Coltene is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
